Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: PEN HSACW UAVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Monday, 15 March 2021 04:30 AM

The Law Offices of Vincent Wong

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / March 15, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Penumbra, Inc. (NYSE:PEN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/penumbra-inc-loss-submission-form?prid=13646&wire=1
Lead Plaintiff Deadline: March 16, 2021
Class Period: August 3, 2020 - December 15, 2020

Allegations against PEN include that: (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of the Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra's public statements as set forth above were materially false and misleading at all relevant times.

Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (NASDAQ:HSACW)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-loss-submission-form?prid=13646&wire=1
Lead Plaintiff Deadline: April 20, 2021
Class Period: October 2, 2019 - February 1, 2021

Allegations against HSACW include that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

AgEagle Aerial Systems, Inc. (NYSE:UAVS)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/ageagle-aerial-systems-inc-loss-submission-form?prid=13646&wire=1
Lead Plaintiff Deadline: April 27, 2021
Class Period: September 3, 2019 - February 18, 2021

Allegations against UAVS include that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public's understanding about a partnership with Amazon, Defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (3) as a result, Defendants' statements about AgEagle's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

The Law Offices of Vincent Wong, Monday, March 15, 2021, Press release picture

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: